Search

Search Constraints

You searched for: Author/Creator Chauchet, Adrien

Search Results

1. Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study. Issue 2 (24th February 2023)

2. Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA). (21st April 2022)

3. CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes. Issue 1 (12th December 2014)

4. Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center. Issue 11 (25th August 2020)

5. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. (October 2020)

6. Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers. Issue 8 (16th August 2018)

7. First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study. Issue 3 (29th December 2020)

8. High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia. Issue 2 (23rd November 2020)

10. Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study. Issue 7 (3rd May 2021)